Influence of CleaRing Open-capsule Device on Refractive Predictability in Cataract Patients (Part 2)
The Hanita CleaRing device is an intraocular implant designed for inhibition of PCO leading to reduction in the Nd:YAG treatment rate. The device is implanted into the capsular bag after the extraction of the crystalline lens and prior to implantation of the IOL. The device is manufactured by Hanita Lenses from a hydrophilic acrylic co-polymer which is being used for the production of Intra-ocular lenses.
• Subject is between 50 and 80 years of age
• Subject is designated for bilateral cataract surgery
• Both eyes fulfil the following criteria:
‣ Potentially able to achieve a good vision (by opinion of the investigator)
⁃ ACD is at least 2.5mm (from epithelium)
⁃ Corneal astigmatism is at most 2.0 dpt
⁃ Axial length is between 22.0 and 26.0 mm
⁃ Able to obtain pupil dilation of at least 6.0 mm
⁃ Average keratometry values between 42.0 and 46.0 D
• Subject understands the study requirements and the treatment procedures and provides written Informed Consent before any study-specific tests or procedures are performed